Patents by Inventor Timothy Scott BUGNI

Timothy Scott BUGNI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250090520
    Abstract: Turbinmicin analogs of Formula I are provided. Compositions including Turbinmicin analogs of Formula I, such as pharmaceutical compositions including effective amounts of Turbinmicin analogs of Formula I for treating fungal infections such as Candida and Aspergillus, including drug-resistant strains thereof, are also disclosed. Methods of treating fungal infections with Turbinmicin analogs of Formula I and compositions thereof are disclosed.
    Type: Application
    Filed: September 26, 2022
    Publication date: March 20, 2025
    Applicant: Wisconsin Alumni Research Foundation
    Inventors: Timothy Scott Bugni, Weiping Tang, Le Guo, Changgui Zhao, Fan Zhang, Douglas R. Braun, David Andes, Miao Zhao, Jenna Lee Fossen
  • Patent number: 10660874
    Abstract: An isolated or synthesized compound of Formula I and salts thereof are provided. A compound isolated from Actinomadura and having a chemical formula of C38H60O12 is also provided. Compositions including the compounds and methods of using the compounds to treat bacterial infections including gram positive infections such as C. difficile are also disclosed.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: May 26, 2020
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Timothy Scott Bugni, Thomas Philip Wyche, Douglas R. Braun, Jeffrey S. Piotrowski, Nasia Safdar
  • Publication number: 20170348278
    Abstract: An isolated or synthesized compound of Formula I and salts thereof are provided. A compound isolated from Actinomadura and having a chemical formula of C38H60O12 is also provided. Compositions including the compounds and methods of using the compounds to treat bacterial infections including gram positive infections such as C. difficile are also disclosed.
    Type: Application
    Filed: October 28, 2015
    Publication date: December 7, 2017
    Inventors: Timothy Scott BUGNI, Thomas Philip WYCHE, Douglas R. BRAUN, Jeffrey S. PIOTROWSKI, Nasia SAFDAR